来源：ACS Chemical Neuroscience, 2010, 1(7): 475-475.
DOI：10.1021/cn100025k
摘要
Sabril (vigabatrin) oral solution was approved by the FDA on August 21st, 2009 for treatment of infantile spasms in children ages 1 month to 2 years and complex partial seizures in adults (tablets).
科研之友
微信
新浪微博
Facebook
分享链接
